Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+239.4%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+239.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
39.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $64.11M | +253.6% |
| 2024 | $-41.73M | -3456.9% |
| 2023 | $1.24M | -24.2% |
| 2022 | $1.64M | +1142.4% |
| 2021 | $132000.00 | +101.3% |
| 2020 | $-10.55M | -665.9% |
| 2019 | $1.86M | +785.3% |
| 2018 | $-272000.00 | - |